603259 Stock Overview An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People’s Republic of China, the United States, Europe, and internationally. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Add noteWuXi AppTec Co., Ltd. Competitors Price History & Performance
Summary of share price highs, lows and changes for WuXi AppTec Historical stock prices Current Share Price CN¥52.61 52 Week High CN¥75.38 52 Week Low CN¥36.36 Beta 0.82 1 Month Change -9.25% 3 Month Change 2.25% 1 Year Change -26.68% 3 Year Change -54.58% 5 Year Change -7.44% Change since IPO 55.98%
Recent News & Updates
WuXi AppTec Co., Ltd. to Report Fiscal Year 2024 Results on Mar 18, 2025 Dec 27
Third quarter 2024 earnings released: EPS: CN¥0.79 (vs CN¥0.94 in 3Q 2023) Oct 29 WuXi Reportedly Explores Sale of Pharma Units as US Restrictions Loom Oct 05
WuXi AppTec Co., Ltd. to Report Q3, 2024 Results on Oct 29, 2024 Sep 30
Investor sentiment improves as stock rises 17% Sep 27 WuXi AppTec Co., Ltd. (SHSE:603259) announces an Equity Buyback for CNY 1,000 million worth of its shares. Sep 11
See more updates
WuXi AppTec Co., Ltd. to Report Fiscal Year 2024 Results on Mar 18, 2025 Dec 27
Third quarter 2024 earnings released: EPS: CN¥0.79 (vs CN¥0.94 in 3Q 2023) Oct 29 WuXi Reportedly Explores Sale of Pharma Units as US Restrictions Loom Oct 05
WuXi AppTec Co., Ltd. to Report Q3, 2024 Results on Oct 29, 2024 Sep 30
Investor sentiment improves as stock rises 17% Sep 27 WuXi AppTec Co., Ltd. (SHSE:603259) announces an Equity Buyback for CNY 1,000 million worth of its shares. Sep 11
Second quarter 2024 earnings released: EPS: CN¥0.79 (vs CN¥1.07 in 2Q 2023) Jul 30
WuXi AppTec Co., Ltd. to Report First Half, 2024 Results on Jul 30, 2024 Jun 28
Dividend increased to CN¥0.99 Jun 22
WuXi AppTec Co., Ltd. Approves Cash Dividend Payment for the Financial Year Ended 31 December 2023, Payable on July 5, 2024 Jun 13
WuXi AppTec Co., Ltd., Annual General Meeting, Jun 12, 2024 May 12
WuXi AppTec Co., Ltd., Annual General Meeting, Jun 12, 2024 May 11
Wuxi Apptec Co., Ltd. Proposes Final Cash Dividend Payment for the Financial Year Ended 31 December 2023 May 10
First quarter 2024 earnings released: EPS: CN¥0.65 (vs CN¥0.74 in 1Q 2023) Apr 30
WuXi AppTec Co., Ltd. Provides Earnings Guidance for the Full Year 2024 Apr 30
WuXi AppTec Co., Ltd. to Report Q1, 2024 Results on Apr 30, 2024 Mar 29
WuXi AppTec Co., Ltd. Proposes Final Ordinary Dividend for the Year Ended December 31, 2023 Mar 20
Full year 2023 earnings released: EPS: CN¥3.27 (vs CN¥3.01 in FY 2022) Mar 19
New minor risk - Share price stability Feb 02
Investor sentiment deteriorates as stock falls 20% Jan 29
WuXi AppTec Co., Ltd. to Report Fiscal Year 2023 Results on Mar 19, 2024 Dec 29
Third quarter 2023 earnings released: EPS: CN¥0.94 (vs CN¥0.93 in 3Q 2022) Oct 31 Wuxi Apptec Co., Ltd. Announces Retirement Proposal of Shuhui Chen from Executive Vice President and Head of Wuxi Ddsu
Second quarter 2023 earnings released: EPS: CN¥1.07 (vs CN¥1.03 in 2Q 2022) Aug 01
WuXi AppTec Co., Ltd. to Report First Half, 2023 Results on Aug 01, 2023 Jun 28
WuXi AppTec Co., Ltd. Announces Executive Changes Jun 07 WuXi AppTec Co., Ltd. Approves Board Changes
Wuxi AppTec Co., Ltd Announces Demise of Ning Zhao, Executive Director and Senior Vice President May 18
Full year 2022 earnings released: EPS: CN¥3.01 (vs CN¥1.75 in FY 2021) Mar 21
Wuxi Apptec Co., Ltd. Provides Earnings Guidance for the Year Ended December 31, 2022 Jan 31
Now 21% undervalued Dec 20
Now 21% undervalued after recent price drop Nov 23
Now 21% undervalued after recent price drop Nov 09
Third quarter 2022 earnings released: EPS: CN¥0.93 (vs CN¥0.30 in 3Q 2021) Oct 28
Investor sentiment improved over the past week Oct 17 WuXi AppTec Co., Ltd. to Report Q3, 2022 Results on Oct 26, 2022
Second quarter 2022 earnings released: EPS: CN¥1.03 (vs CN¥0.40 in 2Q 2021) Jul 29
WuXi AppTec Co., Ltd. to Report First Half, 2022 Results on Jul 26, 2022 Jul 13
Investor sentiment improved over the past week Jun 09
WuXi AppTec Co., Ltd. Reiterates Earnings Guidance for the Second Quarter of 2022 Jun 06
WuXi AppTec Co., Ltd. Announces Management Changes May 26 WuXi AppTec Co., Appoints Minzhang Chen as Director
First quarter 2022 earnings released: EPS: CN¥0.56 (vs CN¥0.52 in 1Q 2021) Apr 27
Less than half of directors are independent Apr 27
WuXi AppTec Co., Ltd. to Report Q1, 2022 Results on Apr 25, 2022 Apr 12
WuXi AppTec Co., Ltd. Provides Earnings Guidance for the First Quarter Ended March 31, 2022 Apr 11
Now 20% undervalued Apr 07
Full year 2021 earnings: EPS in line with expectations, revenues disappoint Feb 17
Investor sentiment deteriorated over the past week Feb 11
Now 20% undervalued after recent price drop Jan 20
WuXi AppTec Co., Ltd. Provides Earnings Guidance for the Year Ended December 31, 2021 Jan 19
WuXi AppTec Co., Ltd. (SHSE:603259) acquired Quality Biotech, Inc. Dec 15
Third quarter 2021 earnings released: EPS CN¥0.30 (vs CN¥0.23 in 3Q 2020) Oct 31
Key Executive recently sold CN¥5.3m worth of stock Sep 30
Co-CEO & Executive Director recently sold CN¥2.8m worth of stock Sep 22
Co-Chief Executive Officer recently sold CN¥1.1m worth of stock Sep 03
Second quarter 2021 earnings released: EPS CN¥0.40 (vs CN¥0.51 in 2Q 2020) Aug 14
WuXi AppTec Co., Ltd. Provides Earnings Guidance for the Six Months Ended June 30, 2021 Jul 16
WuXi AppTec Co., Ltd. Approves the 2020 Profit Distribution Plan May 15
First quarter 2021 earnings released: EPS CN¥0.62 (vs CN¥0.13 in 1Q 2020) May 02
WuXi AppTec Co., Ltd. Provides Revenue Guidance for the Second Half of 2021 Apr 30
Full year 2020 earnings released: EPS CN¥1.27 (vs CN¥0.81 in FY 2019) Apr 01
WuXi AppTec Co., Ltd. to Report Fiscal Year 2020 Results on Mar 30, 2021 Mar 17
Full year 2020 earnings released: EPS CN¥1.27 (vs CN¥0.81 in FY 2019) Mar 07
Revenue beats expectations Mar 07
Quanterix Corporation and WuXi AppTec Enter into an Agreement to Open Joint Simoa Laboratory Feb 13
New 90-day high: CN¥185 Feb 11
New 90-day high: CN¥154 Jan 20
New 90-day high: CN¥123 Dec 17
New 90-day high: CN¥115 Nov 05
WuXi AppTec Co., Ltd. (SHSE:603259) acquired Milestone Pharma. Oct 30
Third quarter earnings released Oct 30
WuXi AppTec Co., Ltd. to Report Q3, 2020 Results on Oct 29, 2020 Oct 16
WuXi AppTec Co., Ltd. announced that it has received CNY 6.527939898 billion in funding from a group of investors Sep 26
WuXi AppTec Co., Ltd. announced that it expects to receive CNY 6.52794 billion in funding from a group of investors Sep 25
First half earnings released Aug 14
WuXi AppTec Co., Ltd. has completed a Follow-on Equity Offering in the amount of HKD 7.366183 billion. Aug 07
WuXi AppTec Co., Ltd. to Report First Half, 2020 Results on Aug 14, 2020 Jul 06 Shareholder Returns 603259 CN Life Sciences CN Market 7D -0.8% -5.2% -4.1% 1Y -26.7% -21.4% 6.9%
See full shareholder returns
Return vs Market: 603259 underperformed the CN Market which returned 6.9% over the past year.
Price Volatility Is 603259's price volatile compared to industry and market? 603259 volatility 603259 Average Weekly Movement 5.6% Life Sciences Industry Average Movement 7.7% Market Average Movement 7.7% 10% most volatile stocks in CN Market 11.6% 10% least volatile stocks in CN Market 4.9%
Stable Share Price: 603259 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 603259's weekly volatility (6%) has been stable over the past year.
About the Company WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People’s Republic of China, the United States, Europe, and internationally. The company operates in six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions that support stand-alone and integrated projects from target discovery to candidate selection and into the clinic.
Show more WuXi AppTec Co., Ltd. Fundamentals Summary How do WuXi AppTec's earnings and revenue compare to its market cap? 603259 fundamental statistics Market cap CN¥150.82b Earnings (TTM ) CN¥8.06b Revenue (TTM ) CN¥38.50b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 603259 income statement (TTM ) Revenue CN¥38.50b Cost of Revenue CN¥22.86b Gross Profit CN¥15.64b Other Expenses CN¥7.57b Earnings CN¥8.06b
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Mar 18, 2025
Earnings per share (EPS) 2.79 Gross Margin 40.61% Net Profit Margin 20.94% Debt/Equity Ratio 10.1%
How did 603259 perform over the long term?
See historical performance and comparison Dividends
1.9% Current Dividend Yield
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2025/01/09 22:50 End of Day Share Price 2025/01/09 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources WuXi AppTec Co., Ltd. is covered by 49 analysts. 23 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Jiangqiao Tong BOCI Research Ltd. Linda Lu BOCI Research Ltd. Yang Luo BOCI Research Ltd.
Show 46 more analysts